Please login to the form below

Not currently logged in
Email:
Password:

OncoMed Pharmaceuticals

This page shows the latest OncoMed Pharmaceuticals news and features for those working in and with pharma, biotech and healthcare.

Sanofi enters vaccines partnership with Sutro

Sanofi enters vaccines partnership with Sutro

Dr Jeremy Bender joined from Allos as chief business officer, while Dr Aaron Sato joined from OncoMed Pharmaceuticals as VP, research.

Latest news

  • Diabetes favoured

    575. Orexo/Ortho-McNeil-Janssen. Small molecules for COPD and asthma. Discovery. 574. Oncomed Pharmaceuticals/Bayer Schering. ... ElexoPharm/Merck &Co. Aldosterone synthase targets for cardiovascular disease. Discovery. 42. Adeona Pharmaceuticals/Meda.

  • GSK to develop cancer drugs with OncoMed

    UK pharmaceutical company GlaxoSmithKline (GSK) and US-based biotech OncoMed Pharmaceuticals have partnered to discover, develop and market antibody therapeutics to target cancer stem cells. ... GSK also has option to license four OncoMed product

More from news
Approximately 0 fully matching, plus 3 partially matching documents found.

Latest appointments

  • OncoMed’s CMO steps down OncoMed’s CMO steps down

    Dr Jakob Dupont to leave the clinical-stage company. OncoMed Pharmaceuticals' Dr Jakob Dupont has resigned as senior vice president and chief medical officer, and is due to step down from ... Paul Hastings, OncoMed's chairman and chief executive officer,

  • Astellas bolsters oncology clinical development leadership Astellas bolsters oncology clinical development leadership

    He brings senior leadership experience in clinical development, compliance and licensing fromOncoMed Pharmaceuticals and PDL BioPharma, as well as academic experience from the University of North Carolina's Chapel Hill School

  • Sutro Biopharma hires chief business officer and VP research Sutro Biopharma hires chief business officer and VP research

    He was also heavily involved in the acquisition of Allos by Spectrum Pharmaceuticals. ... Dr Sato joins Sutro from OncoMed Pharmaceuticals, where he served as senior director of antibody engineering.

More from appointments
Approximately 1 fully matching, plus 2 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Havas Lynx Group

We are the Havas Lynx Group. Devoted to fresh thinking. Changing the way the world does healthcare communications for the...

Latest intelligence

Empowered patients: shaking the foundations of healthcare
Precision medicine represents a new paradigm in healthcare.This new approach to treating and preventing disease views the patient holistically, analysing their genes, environment and lifestyle, and using this information to...
A uniquely English genomic medicine service
The UK National Health Service is developing one standardised approach to embedding precision medicine across the whole of England. Blue Latitude Health speaks to Dr Tom Fowler, Deputy Chief Scientist...
Blended Intelligence
Data is the most valued commodity of the modern world. For P&P it's all about the application....

Infographics